Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Crism Thera (CRTX) Share Price

Price 10.50p on 23-10-2025 at 18:50:06
Change -0.50p -4.55%
Buy 11.00p
Sell 10.00p
Last Trade: Sell 13.00 at 10.23p
Day's Volume: 227,755
Last Close: 10.50p
Open: 11.00p
ISIN: VGG042401262
Day's Range 10.50p - 11.00p
52wk Range: 6.25p - 29.00p
Market Capitalisation: £4.20m
VWAP: 10.5162p
Shares in Issue: 39.96m

Crism Thera (CRTX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 13 10.23p Ordinary
16:05:36 - 23-Oct-25
Buy* 7,544 10.88p Ordinary
15:52:24 - 23-Oct-25
Buy* 8,771 10.88p Ordinary
15:18:46 - 23-Oct-25
Buy* 6,893 10.88p Ordinary
11:42:20 - 23-Oct-25
Sell* 145 10.12p Ordinary
09:57:27 - 23-Oct-25
Sell* 50,000 10.25p Ordinary
08:57:04 - 23-Oct-25
Sell* 45,735 10.43p Ordinary
08:56:54 - 23-Oct-25
Buy* 50,000 10.90p Ordinary
08:53:09 - 23-Oct-25
Buy* 4,595 10.88p Ordinary
08:07:01 - 23-Oct-25
Sell* 15,000 10.41p Ordinary
08:02:37 - 23-Oct-25
See more Crism Thera trades

Crism Thera (CRTX) Share Price History

Time period:
to
Date Open High Low Close Volume
23rd Oct 2025 (Thu) 11.00 11.00 10.50 10.50 227,755
22nd Oct 2025 (Wed) 11.00 11.00 11.00 11.00 37,537
21st Oct 2025 (Tue) 11.00 11.00 11.00 11.00 1,773
20th Oct 2025 (Mon) 11.00 11.00 11.00 11.00 11,401
17th Oct 2025 (Fri) 11.00 11.00 11.00 11.00 438
16th Oct 2025 (Thu) 11.00 11.00 11.00 11.00 24,605
15th Oct 2025 (Wed) 11.00 11.00 11.00 11.00 1,696
14th Oct 2025 (Tue) 11.50 12.50 10.50 11.00 664,259
13th Oct 2025 (Mon) 11.00 11.00 11.00 11.00 36,544
10th Oct 2025 (Fri) 11.00 11.00 11.00 11.00 4,844
9th Oct 2025 (Thu) 11.00 12.00 11.00 11.00 263,319
8th Oct 2025 (Wed) 11.00 11.00 11.00 11.00 93,279
7th Oct 2025 (Tue) 11.00 11.00 11.00 11.00 18,931
6th Oct 2025 (Mon) 11.00 11.00 11.00 11.00 36,774
3rd Oct 2025 (Fri) 11.00 11.00 11.00 11.00 30,629
2nd Oct 2025 (Thu) 11.00 11.00 11.00 11.00 7,620
1st Oct 2025 (Wed) 9.50 11.00 9.50 11.00 126,476
30th Sep 2025 (Tue) 9.50 9.50 9.50 9.50 38,575
29th Sep 2025 (Mon) 9.50 9.50 9.50 9.50 53,218
26th Sep 2025 (Fri) 9.50 9.50 9.50 9.50 219
25th Sep 2025 (Thu) 9.50 9.50 9.50 9.50 20,926
24th Sep 2025 (Wed) 9.50 9.50 9.50 9.50 30,560
See more Crism Thera price history

Crism Thera (CRTX) Regulatory News

Date Source Headline
14th Oct 2025 7:00 am RNS Positive Preclinical Data in Prostate Cancer
15th Sep 2025 7:00 am RNS Half Year Report
12th Sep 2025 7:00 am RNS Notice of Interim Results and IMC Presentation
1st Sep 2025 7:00 am RNS Approval for phase 2 clinical trial
26th Aug 2025 4:03 pm RNS Result of AGM
26th Aug 2025 7:00 am RNS AGM Statement
12th Aug 2025 7:00 am RNS GMP Manufacture of ChemoSeed
4th Aug 2025 5:45 pm RNS Notice of AGM and EMI Option Plan
10th Jul 2025 3:04 pm RNS Holding(s) in Company
3rd Jul 2025 7:00 am RNS Result of Retail Offer and Additional Placing
See more Crism Thera regulatory news

Crism Thera (CRTX) Share News

CRISM reports "significant" preclinical data for prostate cancer drug

14th Oct 2025 16:50

(Alliance News) - CRISM Therapeutics Corp said on Tuesday that preclinical studies show that its ChemoSeed drug delivery platform could "could substantially enhance" the efficacy of docetaxel in the treatment of prostate cancer. Read More

EARNINGS: CRISM loss widens as "actively" prepares for phase 2 trial

15th Sep 2025 21:41

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: CRISM confident in ChemoSeed as targets trial approval

26th Aug 2025 13:56

CRISM Therapeutics Corp - British Virgin Islands-based pharmaceutical firm - As the firm held its annual general meeting, Chair Nermeen Varawalla says the firm must attract, retain and incentivise the best people as it continues to seek further validation for its novel delivery method. "[We] are confident that ChemoSeed has the potential to transform treatment for patients with solid-tumour cancers," Chair Varawalla continues. ChemoSeed is an implantable biodegradable drug delivery technology designed for the sustained delivery of chemotherapy directly into cancer tissue. Chair Varawalla says the company is focused on gaining trial approval from the UK Medicines & Healthcare products Regulatory Agency in glioblastoma and progressing towards dosing first patients in early 2026. Read More

UK shareholder meetings calendar - next 7 days

19th Aug 2025 14:58

Read More

LONDON MARKET MIDDAY: London mixed as mortgage data beats expectations

30th Jun 2025 12:01

(Alliance News) - London stocks were mixed at midday on Monday, as US tariff uncertainty continues to weigh on investor sentiment despite a data reading confirming UK economic growth at the start of the year. Read More

See more Crism Thera news
FTSE 100 Latest
Value9,578.57
Change63.57

Login to your account

Forgot Password?

Not Registered